Literature DB >> 32683438

Predominance of an altered sense of smell or taste among long-lasting symptoms in patients with mildly symptomatic COVID-19.

P Boscolo-Rizzo1, J Polesel2, G Spinato1, A Menegaldo1, C Fabbris1, L Calvanese1, D Borsetto3, C Hopkins3.   

Abstract

There is mounting evidence that a new onset of altered sense of smell or taste is related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. In order to allow patients to recognize symptoms indicative of SARS-CoV-2 infection and self-isolate at the earliest opportunity, self-reported loss of smell and taste have greater value in controlling disease transmis- sion than psychophysical testing, which is not widely available outside of highly specialized clinics.

Entities:  

Mesh:

Year:  2020        PMID: 32683438     DOI: 10.4193/Rhin20.263

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  19 in total

1.  Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.

Authors:  Mackenzie E Hannum; Riley J Koch; Vicente A Ramirez; Sarah S Marks; Aurora K Toskala; Riley D Herriman; Cailu Lin; Paule V Joseph; Danielle R Reed
Journal:  Chem Senses       Date:  2022-01-01       Impact factor: 3.160

2.  Insights into the molecular triggers of parosmia based on gas chromatography olfactometry.

Authors:  Jane K Parker; Christine E Kelly; Simon B Gane
Journal:  Commun Med (Lond)       Date:  2022-05-24

3.  The importance of early detection of ENT symptoms in mild-to-moderate COVID-19.

Authors:  Giacomo Spinato; Giulio Costantini; Cristoforo Fabbris; Anna Menegaldo; Francesca Mularoni; Piergiorgio Gaudioso; Monica Mantovani; Daniele Borsetto; Ananth Vijendren; Maria Cristina Da Mosto; Paolo Boscolo-Rizzo
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-04       Impact factor: 2.124

Review 4.  Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review.

Authors:  Hironori Tsuchiya
Journal:  Dent J (Basel)       Date:  2021-03-11

5.  Prevalence of olfactory dysfunction and quality of life in hospitalised patients 1 year after SARS-CoV-2 infection: a cohort study.

Authors:  Hui Qi Mandy Tan; Alfonso Luca Pendolino; Peter J Andrews; David Choi
Journal:  BMJ Open       Date:  2022-01-25       Impact factor: 2.692

Review 6.  Discrepancies of SARS-CoV-2 testing results among patients with total laryngectomy.

Authors:  C Fabbris; F Boaria; P Boscolo-Rizzo; E Emanuelli; G Spinato
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-12-02       Impact factor: 3.236

7.  Pathophysiology and Management of Tongue Involvement in COVID-19 Patients.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Soheil Ebrahimpour; Alireza Janbakhsh; Mandana Afsharian; Amirhossein Hasanpour; Arefeh Babazadeh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2022-01-06

8.  Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.

Authors:  Silvia Morbelli; Silvia Chiola; Maria Isabella Donegani; Dario Arnaldi; Matteo Pardini; Raffaele Mancini; Francesco Lanfranchi; Francesca D'amico; Matteo Bauckneht; Alberto Miceli; Erica Biassoni; Beatrice Orso; Emanuela Barisione; Luana Benedetti; Sambuceti Gianmario; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-01-05       Impact factor: 10.057

9.  The Effect of Isotonic Saline Nasal Lavages in Improving Symptoms in SARS-CoV-2 Infection: A Case-Control Study.

Authors:  Giacomo Spinato; Cristoforo Fabbris; Giulio Costantini; Federica Conte; Pier Giorgio Scotton; Francesco Cinetto; Rosalba De Siati; Alessandro Matarazzo; Marco Citterio; Giacomo Contro; Cosimo De Filippis; Carlo Agostini; Enzo Emanuelli; Paolo Boscolo-Rizzo; Daniele Frezza
Journal:  Front Neurol       Date:  2021-12-06       Impact factor: 4.003

Review 10.  Post-viral effects of COVID-19 in the olfactory system and their implications.

Authors:  Michael S Xydakis; Mark W Albers; Eric H Holbrook; Dina M Lyon; Robert Y Shih; Johannes A Frasnelli; Axel Pagenstecher; Alexandra Kupke; Lynn W Enquist; Stanley Perlman
Journal:  Lancet Neurol       Date:  2021-07-30       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.